Total Payments
$6,904
2023 Payments
$511.09
Companies
61
Transactions
403
Medicare Patients
1,529
Medicare Billing
$133,234
Payment Breakdown by Category
Food & Beverage$6,784 (98.3%)
Education$104.40 (1.5%)
Other$15.16 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,784 | 385 | 98.3% |
| Education | $104.40 | 17 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.16 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $714.23 | 39 | $0 (2023) |
| Amgen Inc. | $666.29 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $504.65 | 23 | $0 (2022) |
| Amarin Pharma Inc. | $493.75 | 34 | $0 (2021) |
| Novo Nordisk Inc | $458.18 | 32 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $400.19 | 35 | $0 (2021) |
| PFIZER INC. | $298.58 | 21 | $0 (2023) |
| GlaxoSmithKline, LLC. | $248.38 | 11 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $227.03 | 11 | $0 (2021) |
| Lilly USA, LLC | $207.88 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $511.09 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($131.70) |
| 2022 | $785.72 | 50 | Novo Nordisk Inc ($179.95) |
| 2021 | $1,376 | 80 | CSL Behring ($201.47) |
| 2020 | $851.78 | 52 | CSL Behring ($140.65) |
| 2019 | $1,311 | 77 | CSL Behring ($201.89) |
| 2018 | $961.91 | 50 | AstraZeneca Pharmaceuticals LP ($203.81) |
| 2017 | $1,107 | 70 | AstraZeneca Pharmaceuticals LP ($173.10) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $25.28 | General |
| 09/06/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 08/31/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.99 | General |
| 08/24/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: SLEEP MEDICINE | ||||||
| 08/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 08/15/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/03/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: VACCINES | ||||||
| 07/20/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PAIN | ||||||
| 07/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $21.66 | General |
| 07/06/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 06/29/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Urology | ||||||
| 05/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GAMMAGARD (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Diabetes Care | ||||||
| 04/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GAMMAGARD (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Oncology | ||||||
| 04/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $21.00 | General |
| 03/23/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Oncology | ||||||
| 02/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 01/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: INSOMNIA | ||||||
| 01/04/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Adenosine A2A Receptors | ||||||
| 12/13/2022 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 271 | 500 | $76,014 | $26,292 |
| 2022 | 12 | 438 | 780 | $99,101 | $41,551 |
| 2021 | 10 | 318 | 445 | $69,048 | $27,156 |
| 2020 | 9 | 502 | 667 | $109,901 | $38,236 |
Total Patients
1,529
Total Services
2,392
Medicare Billing
$133,234
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 176 | $45,065 | $14,331 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $9,248 | $4,730 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 69 | $12,170 | $4,127 | 33.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 21 | 21 | $2,100 | $1,592 | 75.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $1,070 | $563.04 | 52.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 31 | 31 | $1,906 | $559.50 | 29.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 34 | $1,113 | $319.48 | 28.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 114 | $3,342 | $69.89 | 2.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 174 | $39,846 | $14,883 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $10,600 | $7,118 | 67.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 81 | $12,312 | $5,169 | 42.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 58 | 58 | $8,700 | $4,320 | 49.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $4,900 | $3,856 | 78.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 33 | 35 | $4,195 | $2,379 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 35 | $1,750 | $1,064 | 60.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 54 | 54 | $7,020 | $1,023 | 14.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 68 | $3,536 | $742.18 | 21.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 12 | 14 | $2,142 | $428.82 | 20.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $500.00 | $417.60 | 83.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 16 | 180 | $3,600 | $151.77 | 4.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 150 | $34,350 | $12,417 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 38 | 38 | $7,600 | $5,211 | 68.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 81 | $12,312 | $4,648 | 37.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 27 | 27 | $2,145 | $1,758 | 82.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 43 | 43 | $5,590 | $832.48 | 14.9% |
About Dr. Luis Gonzalez, M.D
Dr. Luis Gonzalez, M.D is a Internal Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932186251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Gonzalez, M.D has received a total of $6,904 in payments from pharmaceutical and medical device companies, with $511.09 received in 2023. These payments were reported across 403 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($6,784).
As a Medicare-enrolled provider, Gonzalez has provided services to 1,529 Medicare beneficiaries, totaling 2,392 services with total Medicare billing of $133,234. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Baytown, TX
- Active Since 12/28/2005
- Last Updated 01/20/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932186251
Products in Payments
- Hizentra (Biological) $714.23
- Vascepa (Drug) $493.75
- FARXIGA (Drug) $469.56
- Prolia (Biological) $339.22
- Aimovig (Biological) $278.55
- VRAYLAR (Drug) $186.53
- XARELTO (Drug) $183.73
- Ozempic (Drug) $179.19
- AIMOVIG (Biological) $156.04
- JARDIANCE (Drug) $154.52
- BELSOMRA (Drug) $137.98
- Rybelsus (Drug) $134.00
- ANORO (Drug) $122.04
- INGREZZA (Drug) $114.38
- JANUVIA (Drug) $108.90
- Myrbetriq (Drug) $107.06
- NEXLETOL (Drug) $107.01
- Victoza (Drug) $106.02
- TRULICITY (Drug) $100.16
- NURTEC ODT (Drug) $100.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baytown
Dr. Dinara Rose, M.d, M.D
Internal Medicine — Payments: $7,729
Internal Medicine $7,729
Atif Qureshi, M.d, M.D
Internal Medicine — Payments: $6,870
Internal Medicine $6,870
Shehzad Sami, Md, MD
Internal Medicine — Payments: $5,864
Internal Medicine $5,864
Kamran Khan, Md, MD
Internal Medicine — Payments: $4,512
Internal Medicine $4,512
Dr. Niravkumar Naik, M.d, M.D
Internal Medicine — Payments: $4,481
Internal Medicine $4,481
Shehpar Khan, M.d, M.D
Internal Medicine — Payments: $4,172
Internal Medicine $4,172